WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak.

WHO vaccine experts have recommended a full-scale human trial of the approved Ervebo Ebola vaccine to assess its cross-protection against the deadly Bundibugyo strain rapidly spreading in the Democratic Republic of Congo. The outbreak has surpassed 4,000 confirmed cases, with 1,850 deaths.